New York 2025-2026 Regular Session

New York Assembly Bill A07869

Introduced
4/11/25  
Refer
4/11/25  

Caption

Authorizes prescription labels to include symptom or purpose for which the drug is being prescribed if the patient requests from their health care provider that such information be disclosed on the label, with exceptions.

Summary

Bill A07869 amends the education law to allow patients to request that their prescription labels include the symptom or purpose for which the drug is being prescribed. This change aims to enhance patient understanding and engagement in their treatment by providing more information directly on the medication label. The amendment specifies that this information can be included unless the prescription is for off-label use, ensuring that patients are informed while also protecting the discretion of healthcare providers in certain circumstances.

Impact

If enacted, this bill would modify the existing requirements for prescription labeling in New York State, impacting healthcare providers, pharmacists, and patients. It would require that, upon patient request, additional information about the purpose of the medication be included on the label, thereby promoting transparency and potentially improving patient adherence to prescribed therapies. This change may also necessitate updates to pharmacy practices and labeling systems to accommodate the new requirements.

Sentiment

The sentiment surrounding Bill A07869 appears to be generally supportive among healthcare advocates and patient rights groups, who see the value in providing patients with more information about their medications. However, there may be concerns from some healthcare providers regarding the implications of labeling requirements and the potential for confusion regarding off-label prescriptions.

Contention

Notable points of contention may arise from healthcare providers who are concerned about the practicality of including additional information on prescription labels, particularly in cases of off-label use. Some may argue that this could lead to misunderstandings or misuse of medications if patients misinterpret the information. Additionally, there may be differing opinions on the necessity of such a requirement and its impact on the prescribing process.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.